AcquisitionOther
Gyre Therapeutics, Inc. acquired Cullgen Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Gyre Therapeutics, Inc. -> Cullgen Inc. · approximately $300 million
Adds targeted protein degradation platform and pipeline, creates fully integrated biopharmaceutical company with U.S. and China capabilities.
Open source record (SEC) ↗